DUBLIN--(BUSINESS WIRE)--The "Exosomes - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Exosomes Market to Reach $1.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Exosomes estimated at US$334.6 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 18.4% over the period 2020-2027.
Isolation Methods, one of the segments analyzed in the report, is projected to record 16.8% CAGR and reach US$579.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Downstream Analysis segment is readjusted to a revised 20.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $99.1 Million, While China is Forecast to Grow at 17.8% CAGR
The Exosomes market in the U.S. is estimated at US$99.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$189.8 Million by the year 2027 trailing a CAGR of 17.8% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.6% and 16% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- Impact of Covid-19 and a Looming Global Recession
- World Current & Future Analysis for Exosomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Isolation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Downstream Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Neurodegenerative diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Cardiovascular diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Infectious diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
III. MARKET ANALYSIS
IV. COMPETITION
(Total 46 Featured):
- Danaher Corporation
- Diagenode SA
- FUJIFILM Holdings Corporation
- Hitachi Chemical Co America Ltd.
- Lonza Group Ltd.
- MBL International Corporation
- Miltenyi Biotec GmbH
- Novus Biologicals LLC
- QIAGEN GmbH
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/j5wqum
